AlphaQuest LLC grew its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD – Free Report) by 250.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,906 shares of the medical instruments supplier’s stock after purchasing an additional 1,362 shares during the quarter. AlphaQuest LLC’s holdings in Mettler-Toledo International were worth $2,657,000 at the end of the most recent quarter.
Other large investors have also recently made changes to their positions in the company. Principal Financial Group Inc. grew its holdings in Mettler-Toledo International by 2.9% during the 3rd quarter. Principal Financial Group Inc. now owns 298,429 shares of the medical instruments supplier’s stock worth $366,354,000 after acquiring an additional 8,360 shares in the last quarter. Nordea Investment Management AB grew its holdings in Mettler-Toledo International by 11.9% during the 4th quarter. Nordea Investment Management AB now owns 157,457 shares of the medical instruments supplier’s stock worth $220,718,000 after acquiring an additional 16,777 shares in the last quarter. Machina Capital S.A.S. bought a new position in Mettler-Toledo International during the 3rd quarter worth about $1,186,000. Citigroup Inc. grew its holdings in Mettler-Toledo International by 4.8% during the 3rd quarter. Citigroup Inc. now owns 65,033 shares of the medical instruments supplier’s stock worth $79,835,000 after acquiring an additional 2,989 shares in the last quarter. Finally, Thrivent Financial for Lutherans grew its holdings in Mettler-Toledo International by 752.2% during the 3rd quarter. Thrivent Financial for Lutherans now owns 73,586 shares of the medical instruments supplier’s stock worth $90,335,000 after acquiring an additional 64,951 shares in the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several research analysts have issued reports on the stock. Wall Street Zen cut shares of Mettler-Toledo International from a “buy” rating to a “hold” rating in a report on Saturday, May 16th. Citigroup cut their price objective on shares of Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating on the stock in a report on Friday, May 8th. Morgan Stanley cut their price target on shares of Mettler-Toledo International from $1,475.00 to $1,275.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 12th. JPMorgan Chase & Co. cut their price target on shares of Mettler-Toledo International from $1,413.00 to $1,200.00 and set a “neutral” rating on the stock in a report on Monday, May 11th. Finally, Barclays cut their price target on shares of Mettler-Toledo International from $1,550.00 to $1,500.00 and set an “overweight” rating on the stock in a report on Tuesday, April 14th. Six equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Mettler-Toledo International presently has an average rating of “Moderate Buy” and an average target price of $1,408.55.
Mettler-Toledo International Trading Down 0.2%
Mettler-Toledo International stock opened at $1,101.26 on Wednesday. Mettler-Toledo International, Inc. has a 12 month low of $1,023.05 and a 12 month high of $1,525.17. The stock’s 50 day simple moving average is $1,224.79 and its two-hundred day simple moving average is $1,337.48. The firm has a market cap of $22.26 billion, a PE ratio of 25.83, a P/E/G ratio of 2.30 and a beta of 1.31.
Mettler-Toledo International (NYSE:MTD – Get Free Report) last announced its earnings results on Thursday, May 7th. The medical instruments supplier reported $8.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $8.70 by $0.21. Mettler-Toledo International had a negative return on equity of 622.80% and a net margin of 21.40%.The firm had revenue of $947.13 million for the quarter, compared to analyst estimates of $943.14 million. During the same quarter last year, the firm posted $8.19 EPS. The business’s revenue was up 7.2% on a year-over-year basis. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. On average, equities research analysts forecast that Mettler-Toledo International, Inc. will post 46.6 EPS for the current year.
About Mettler-Toledo International
Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.
The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.
Further Reading
- Five stocks we like better than Mettler-Toledo International
- Banks Are Buying Back Stock Hand Over Fist, Including These 3 Names
- 2 Aluminum Stocks Poised for Big Tariff-Related Gains
- AutoZone’s Pullback Sets Up a Long-Term Buying Opportunity
- AST SpaceMobile’s June Launch Plan Puts Its 2026 Satellite Goal Back in Focus
Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International, Inc. (NYSE:MTD – Free Report).
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
